MedPath

漯河汇盛药业有限公司

Ownership
-
Established
2019-01-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Pipemidic acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H41022215
Approval Date
Mar 10, 2025
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H20045676
Approval Date
Mar 10, 2025
NMPA

Multienzyme Tablets

Product Name
多酶片
Approval Number
国药准字H20045675
Approval Date
Jun 5, 2020
NMPA

Compound Diclofenac Sodium Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H41024688
Approval Date
Jun 1, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H41022208
Approval Date
Jun 1, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H41022213
Approval Date
Jun 1, 2020
NMPA

Compound Hepar Extractum Tablets

Product Name
复方肝浸膏片
Approval Number
国药准字H41024810
Approval Date
Jun 1, 2020
NMPA

胎盘片

Approval Number
国药准字Z41021507
Approval Date
Jun 1, 2020
NMPA

Calcium Hydrogen Phosphate Tablets

Product Name
磷酸氢钙片
Approval Number
国药准字H41022209
Approval Date
Jun 1, 2020
NMPA

安络痛片

Approval Number
国药准字Z41021506
Approval Date
Jun 1, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.